Literature DB >> 31291632

More than Heart Failure: Central Sleep Apnea and Sleep-Related Hypoventilation.

Simon Dominik Herkenrath1, Winfried Johannes Randerath2.   

Abstract

Central sleep apnea (CSA) comprises a variety of breathing patterns and clinical entities. They can be classified into 2 categories based on the partial pressure of carbon dioxide in the arterial blood. Nonhypercapnic CSA is usually characterized by a periodic breathing pattern, while hypercapnic CSA is based on hypoventilation. The latter CSA form is associated with central nervous, neuromuscular, and rib cage disorders as well as obesity and certain medication or substance intake. In contrast, nonhypercapnic CSA is typically accompanied by an overshoot of the ventilation and often associated with heart failure, cerebrovascular diseases, and stay in high altitude. CSA and hypoventilation syndromes are often considered separately, but pathophysiological aspects frequently overlap. An integrative approach helps to recognize underlying pathophysiological mechanisms and to choose adequate therapeutic strategies. Research in the last decades improved our insights; nevertheless, diagnostic tools are not always appropriately chosen to perform comprehensive sleep studies. This supports misinterpretation and misclassification of sleep disordered breathing. The purpose of this article is to highlight unresolved problems, raise awareness for different pathophysiological components and to discuss the evidence for targeted therapeutic strategies.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Central sleep apnea; Hypoventilation; Sleep apnea and cardiovascular diseases

Year:  2019        PMID: 31291632     DOI: 10.1159/000500728

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  2 in total

1.  Obese Patients Experience More Severe CSA than Non-Obese Patients.

Authors:  Yao-Ching Huang; Shi-Hao Huang; Ren-Jei Chung; Bing-Long Wang; Chi-Hsiang Chung; Wu-Chien Chien; Chien-An Sun; Pi-Ching Yu; Chieh-Hua Lu
Journal:  Int J Environ Res Public Health       Date:  2022-01-24       Impact factor: 3.390

2.  A 7-year-old boy with recurrent cyanosis and tachypnea: A case report.

Authors:  Shu Li; Li-Na Chen; Lin Zhong
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.